Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Biochemotherapy vs Interferon Alfa-2b in Melanoma
NCT00002882Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 1995
- Primary completion
- Aug 2003
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), vinblastine, dacarbazine, aldesleukin in melanoma, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 1995; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)vinblastinedacarbazinealdesleukin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002882.